NCT06410326View on ClinicalTrials.gov

Mapping the Longitudinal, Multidimensional Impact of MS in Relation to Variables Indicative of Neurological Reserve

CompletedOBSERVATIONAL

Enrollment

2,600

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions

Multiple Sclerosis

Trial Locations (1)

1820

Nationaal Multiple Sclerose Centrum Melsbroek, Melsbroek

All Listed Sponsors

collaborator

Vrije Universiteit Brussel

OTHER

lead

National MS Center Melsbroek

OTHER